CDER Officials Testify On Behind-The-Scenes Maneuvers In Plan B Rejection
This article was originally published in The Tan Sheet
Executive Summary
The initial rejection of Barr's Rx-to-OTC switch application for Plan B may have been intended to lead eventually to a restricted approval, according to deposition testimony from FDA officials